Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells

Clinical and Experimental Allergy

Volumn 32, Issue 12, 2002, Pages 1782-1786

  Oda, N ^a   Minoguchi, Kenji ^a   Tanaka, A ^a   Yokoe, T ^a   Minoguchi, H ^a   Matsuo, H ^a   Nakashima, M ^a   Tasaki, T ^a   Adachi, M ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Asthma; Interferon ; Interleukin 4; Suplatast tosilate; T cell; Thymus and activation regulated chemokine

Indexed keywords

GAMMA INTERFERON; HOUSE DUST ALLERGEN; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; PHYTOHEMAGGLUTININ; SUPLATAST TOSYLATE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; ANTIALLERGIC AGENT; ARYLSULFONIC ACID DERIVATIVE; CHEMOKINE; SULFONIUM DERIVATIVE; TUBERCULIN;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES FARINAE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; ASTHMA; BIOSYNTHESIS; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; THYMUS;

ADULT; ANTI-ALLERGIC AGENTS; ANTIGENS, DERMATOPHAGOIDES; ARYLSULFONATES; ASTHMA; CELL LINE; CHEMOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONIUM COMPOUNDS; TH1 CELLS; TH2 CELLS; THYMUS GLAND; TUBERCULIN;

EID: 0036456706     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2002.01547.x     Document Type: Article

References (24)

1. Metzger WJ, Zavala D, Richerson HB et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Am Rev Respir Dis 1987; 135:433-40.
2. Tomioka M, Ida S, Shindoh Y et al. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis 1984; 129:1000-5.
3. Kirby JG, Hargreave FE, Gleich GJ, O'Byrne PM. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987; 136:379-83.
4. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. No. 97-4051. Bethesda, MD: National Institutes Of Health, 1997.
5. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12:227-57.
6. Robinson DS, Hamid Q, Ying S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
7. Walker C, Bode E, Boer L et al. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146:109-15.
8. Tang HL, Cyster JG. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 1999; 284:819-22.
9. Imai T, Nagira M, Takagi S et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus- and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999; 11:81-8.
10. Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107:53541.
11. Sekiya T, Miyamasu M, Imanishi M et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000; 165:2205-13.
12. Kawasaki S, Takizawa H, Yoneyama H et al. Intervention of thymus- and activation-regulated chemokine attenuates the developement of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 2001; 166:2055-62.
13. Matsuura N, Mori H, Nagai H et al. Effect of suplatast tosilate (IPD-1151 T) on types I-IV allergic reactions. Folia Pharmacol Japan 1992; 100:495-501.
14. Togawa M, Ono N, Matsuura N. Effect of suplatast tosilate (IPD-1151 T) on experimental allergic rhinitis in rats. Jap Pharmacol Ther 1992; 20:243742.
15. Yanagihara Y, Kiniwa M, Ikizawa K et al. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (1) Regulation of murine IgE response. Japan J Pharmacol 1993; 61:23-30.
16. Oda N, Minoguchi K, Yokoe T et al. Effect of suplatast tosilate (IPD-1151 T) on cytokine production by allergen-specific human Th1 and Th2 cell lines. Life Sci 1999; 65:763-70.
17. Shim JJ, Dabbagh K, Takeyama K et al. Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice. J Allergy Clin Immunol 2000; 105:73945.
18. Sano Y, Miyamoto T, Makino S. Anti-inflammatory effect of suplatast tosilate on mild asthma. Chest 1997; 112:862-3.
19. Tamaoki J, Kondo M, Sakai N et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma; a doubleblind randomized study. Lancet 2000; 356:273-8.
20. Oda N, Yamashita N, Minoguchi K et al. Long-term analysis of allergen-specific T cell clones from patients with asthma treated with allergen rush immunotherapy. Cell Immunol 1998; 190:43-50.
21. Kohno Y, Minoguchi K, Oda N et al. Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma. J Allergy Clin Immunol 1998; 102:927-34.
22. Mathew A, MacLean JA, DeHaan E et al. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med 2001; 193:1087-96.
23. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187:875-83.
24. Lavareille A, Roufosse F, Schandene L et al. Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo. Eur J Immunol 2001; 31:1037-46.